FRI0253 Trends for gout in adults in an urban area for a 5-year period: incidence, prevalence and hospitalisation rates
Authors: V. Dostanko, V. Yagur, V. Apanasovich, N. Dostanko, A. Rekun
Journal: Annals of the Rheumatic Diseases (2018)

<h3>Background</h3> Gout is one of the most common arthritis nowadays which has a great influence on patient's quality of life, course and outcomes of cardiovascular and renal pathology.<sup><sup>1</sup></sup> Some recent papers demonstrate that the prevalence of gout has risen over the last decades and underline the scarcity or lack of epidemiologic data in different countries as well as the notable variations among them.<sup><sup>2,3</sup></sup> <h3>Objectives</h3> We estimated incidence, prevalence and hospitalisation rates for gout in Minsk (the Republic of Belarus) for the 5 year period (2011–2015). <h3>Methods</h3> Minsk is a typical urban area which is considered to be representative for the urban population of the whole country. The data on the new onset gout and the first visit for gout in a corresponding year were collected from all rheumatologic services of Minsk for the 5 year period from January, 1 of 2011 to December, 31of 2015. Only patients older than 18 years old with the diagnosis of gout according to the ICD-10 (M10) were included. The data on age and sex structure of the population of the Republic of Belarus were obtained from the annual Statistical bulletins of the National Statistical Committee of the Republic of Belarus. Hospitalisation rates were calculated on the base of statistical reports on discharges for the corresponding year. <h3>Results</h3> There were no significant differences in age and sex structure of the population in Belarus and Minsk for the study period. The size of the adult population, incidence and prevalence of gout, hospitalisation rates and duration of hospitalizations for gout for the corresponding years in Minsk are presented in the table 1. According to these data the gout incidence for the 5 year period changed from 25.0 (CI 95% 24.7–25.2) to 35.5 (CI 95% 35.3–35.8) per 100 000 adults, the gout prevalence for the period 2011–2015 also increased from 178.9 (CI 95% 178.3–179.5) to 290.3 (CI 95% 289.6–291.0) per 100 000 adults (p&lt;0.001 for both trends). There were 2688 hospitalizations in Minsk for gout for the study period. The mean age of hospitalised patients was 57.3±10.3 years (median 58.0; range 25–87), 91.4% were men (92%; 87.8%–94.9%). It is worth noting that 45.6% of hospitalised patients were at the age 55–65% and 90.2% were under 70 years old with sharp decrease of hospitalizations after 65 years of age. Hospitalisation rates also increased from 28.7 to 38.2 per 100 000 adults (p&lt;0.001). The mean duration of hospitalisation was 12.5±2.7 days (13 days; 2–26 days) and increased from 11.6 to 12.7 (p=0.03). <h3>Conclusions</h3> We revealed significant increase in incidence, prevalence as well as hospitalisation rates for gout in adults in Minsk (the Republic of Belarus) for the 5 year period (2011–2015) in 1.4, 1.6 and 1.3 times, correspondingly. <h3>References</h3> [1] Kuo CF, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheum2015;11(11):649–62. [2] Roddy E, Choi H. Epidemiology of Gout. Rheum Dis Clin North Am. 2014;40(2):155–175. [3] Dehlin M, et al. Incidence and prevalence of gout in Western Sweden. Arthritis Res Ther2016;18:164. <h3>Disclosure of Interest</h3> None declared